Use of three-dimensional tissue cultures to model extravascular transport and predict in vivo activity of hypoxia-targeted anticancer drugs

被引:121
作者
Hicks, Kevin O.
Pruijn, Frederik B.
Secomb, Timothy W.
Hay, Michael P.
Hsu, Richard
Brown, J. Martin
Denny, William A.
Dewhirst, Mark W.
Wilson, William R.
机构
[1] Univ Auckland, Auckland Canc Soc Res Ctr, Auckland 1, New Zealand
[2] Univ Arizona, Dept Physiol, Tucson, AZ USA
[3] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA
[4] Duke Univ, Dept Radiat Oncol, Durham, NC USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2006年 / 98卷 / 16期
关键词
D O I
10.1093/jnci/djj306
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Because of the inefficient vasculature of solid tumors, anticancer drugs must penetrate relatively long distances through the extravascular compartment. The requirement for such diffusion may limit their activity, especially that of hypoxia-targeted drugs. We tested whether a three-dimensional pharmacokinetic/pharmacodynamic (PK/PD) model based on a representative mapped tumor microvascular network could predict the therapeutic activity of anticancer drugs in mouse xenograft tumors. Methods: Diffusion coefficients of the hypoxia-activated anticancer drug tirapazamine (TPZ) and of 15 TPZ analogs were estimated by measuring their transport through HT29 colon cancer multicellular layers (MCLs). Anoxic cytotoxic potency (by clonogenic assay) and metabolism of the TPZ analogs were measured in HT29 cell suspensions, and their plasma pharmacokinetics was measured in CD-1 nude mice. This information was used to create a spatially resolved PK/PD model for the tumor microvascular network. Model predictions were compared with actual hypoxic cell kill as measured by clonogenic assays on HT29 xenograft tumors 18 hours after treatment with each TPZ analog. Results: Modeling TPZ transport in the tumor microvascular network showed substantial drug depletion in the most hypoxic regions, with predicted maximum cell kill of only 3 logs, compared with more than 10 logs if there were no transport impediment. A large range of tissue diffusion coefficients (0.027x10(-6)-1.87x10(-6) cm(2)/s) was observed for the TPZ analogs. There was a strong correlation between model-predicted and measured hypoxic cell kill (R-2=0.89) but a poor correlation when the model did not include extravascular transport (R-2=0.32). Conclusions: Extravascular transport in tumors, and its consequences for tumor cell killing, can be predicted by measuring drug penetration through MCLs in vitro and modeling pharmacokinetics at each position in three-dimensional microvascular networks.
引用
收藏
页码:1118 / 1128
页数:11
相关论文
共 42 条
[1]   Activation of 3-amino-1,2,4-benzotriazine 1,4-dioxide antitumor agents to oxidizing species following their one-electron reduction [J].
Anderson, RF ;
Shinde, SS ;
Hay, MP ;
Gamage, SA ;
Denny, WA .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2003, 125 (03) :748-756
[2]  
BAKER MA, 1988, CANCER RES, V48, P5947
[3]   Exploiting tumour hypoxia in cancer treatment [J].
Brown, JM ;
William, WR .
NATURE REVIEWS CANCER, 2004, 4 (06) :437-447
[4]  
Bussink J, 2000, RADIAT RES, V154, P547, DOI 10.1667/0033-7587(2000)154[0547:OSBOTM]2.0.CO
[5]  
2
[6]   Vascular architecture and microenvironmental parameters in human squamous cell carcinoma xenografts, effects of carbogen and nicotinamide [J].
Bussink, J ;
Kaanders, JHAM ;
Rijken, PFJW ;
Peters, JPW ;
Hodgkiss, RJ ;
Marres, HAM ;
van der Kogel, AJ .
RADIOTHERAPY AND ONCOLOGY, 1999, 50 (02) :173-184
[7]   DNA cleavage by the antitumor agent 3-amino-1,2,4-benzotriazine 1,4-dioxide (SR4233): Evidence for involvement of hydroxyl radical [J].
Daniels, JS ;
Gates, KS .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1996, 118 (14) :3380-3385
[8]   Improved potency of the hypoxic cytotoxin tirapazamine by DNA-targeting [J].
Delahoussaye, YM ;
Hay, MP ;
Pruijn, FB ;
Denny, WA ;
Brown, JM .
BIOCHEMICAL PHARMACOLOGY, 2003, 65 (11) :1807-1815
[9]  
DEWHIRST MW, 1994, CANCER RES, V54, P3333
[10]   The relationship between the tumor physiologic microenvironment and angiogenesis [J].
Dewhirst, MW ;
Richardson, R ;
Cardenas-Navia, I ;
Cao, YT .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2004, 18 (05) :973-+